National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

What changed today in Aesthetics & Longevity: 2 trial updates, 1 new study

Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.

The signal

NPHLA tracked 3 new official records on this desk today: 1 new study, 2 trial updates.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

  1. New research in Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery: “Efficacy of platelet-rich plasma versus growth factor concentrate in androgenetic alopecia: a systematic review”.[1]
  2. New trial registered: AGA (Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial)[2]
  3. New trial registered: Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study[3]
  4. Also reported by Dermatology Times: “Journal Digest: October 7, 2026”.[4]

Who this affects

  • Med spas
  • Medical directors
  • Prescribers
  • Practice owners & operators
  • Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
    Efficacy of platelet-rich plasma versus growth factor concentrate in androgenetic alopecia: a systematic review (opens the source in a new tab)

    Peer reviewedJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery

  2. [2]
  3. [3]
  4. [4]
    Journal Digest: October 7, 2026 (opens the source in a new tab)

    News reportingDermatology TimesIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

  1. First published.
  2. Added 2 new official records.